On Thursday shares of Bristol-Myers Squibb Company (NYSE:BMY) closed at $67.45. Company’s sales growth for last 5 years was -3.30% and EPS growth for next 5 years is recorded as 16.39%. Bristol-Myers Squibb Company (NYSE:BMY) announced that pursuant to its previously announced cash tender offer for up to $400 million aggregate principal amount (the “tender cap”) of certain of its outstanding debt securities approximately $534.4 million in aggregate principal amount of the notes.
Minerva Neurosciences, Inc. (NASDAQ:NERV) in last trading activity fell -1.55% to close at $5.07. Company weekly performance is -1.55% while its quarterly performance stands at 10.58%. Minerva Neurosciences, Inc. (NASDAQ:NERV) is -49.30% away from its 52 week high. Minerva Neurosciences Inc. (NASDAQ:NERV) on 7 May, reported a loss of $6.1 million in its first quarter. The Waltham, Massachusetts-based company said it had a loss of 31 cents per share. Minerva Neurosciences shares have fallen 15 percent since the beginning of the year.
Intel Corporation (NASDAQ:INTC) in last trading activity advanced 1.01% to close at $32.97. Company weekly performance is 2.26% while its quarterly performance stands at -2.70%. Intel Corporation (NASDAQ:INTC) is -11.75% away from its 52 week high. Intel Corporation (NASDAQ:INTC) announced plans to develop integrated products with eASIC Corporation that combine processing performance and customizable hardware to meet the increasing demand for custom compute solutions for data centers and the “cloud.”
Zions Bancorporation (NASDAQ:ZION) has 1.20% insider ownership while its institutional ownership stands at 87.10%. In last trading activity company’s stock closed at $29.16. Scott J. McLean, President of Zions Bancorporation (NASDAQ: ZION), will make a presentation at the Barclays Americas Select Franchise Conference 2015 on Tuesday, May 19, 2015 at 1:00 p.m. BST.
On last trading day ICU Medical, Inc. (NASDAQ:ICUI) increased 1.73% to close at $96.56. Its volatility for the week is 2.38% while volatility for the month is 2.43%. ICUI’s sales growth for past 5 years was 6.20% and its EPS growth for past 5 years was 0.10%. ICU Medical, Inc. (NASDAQ:ICUI) monthly performance is 6.14%. ICU Medical Inc. (NASDAQ:ICUI) on 5 May, reported first-quarter net income of $9.7 million. The San Clemente, California-based company said it had net income of 60 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.02 per share.